Inaktiver Wert

Andere Sprachen HLB Inc Korea S.E.

Aktien

Schlusskurs Korea S.E. Andere Börsenplätze
-	-

21.03.	HLB Co. Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Südkoreanische Aktien geben am zweiten Tag wegen Gewinnmitnahmen geringfügig nach	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	01.04.
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	22.03.
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors	22.03.
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21.03.
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors	08.03.
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors	04.03.
Bank of Canada Holds Rates Steady; ECB Expected -2-	25.01.
South Korean Shares Marginally Decline for Second Day on Profit-Booking	22.12.
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ	22.12.
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%	22.11.
Century Sunshine Group’s Auditor Resigns; Successor Named	17.11.
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed	17.11.
Jinhai International Gets New Auditor	14.11.
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal	04.10.23
Spenda Halts Trade Pending Court Nod for Auditor Appointment	04.09.23
5E Resources Appoints New Auditors	01.09.23
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.	11.08.23
USA: ouragans et maladie font grimper le cours du jus d'orange à un record	10.08.23
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd.	09.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen HLB Inc Korea S.E.

Aktien

Andere Sprachen

Filter